An analysis of 20 pairs of CRC and adjacent non-tumor colon tissue by immunohistochemistry revealed that CDK9 expression was increased significantly in tumor versus non-tumor tissue, suggesting CDK9 as a potentially suitable therapeutic target also in this large tumor entity (Fig. 6a). Here, CDK9 is linked to colorectal carcinoma.